Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial

Study Purpose

This phase III trial studies how well lenalidomide in combination with ixazomib works compared to lenalidomide alone in treating patients with evidence of residual multiple myeloma after stem cell transplantation. Lenalidomide may help shrink or slow the growth of multiple myeloma. Ixazomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving lenalidomide and ixazomib together may work better than giving lenalidomide alone in treating patients with evidence of residual multiple myeloma after a stem cell transplantation.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - STEP 0: PRE-REGISTRATION.
  • - Patient must be >= 18 years of age.
  • - Patient must be previously diagnosed with multiple myeloma (MM) and be on lenalidomide maintenance with >= 5mg daily for at least 6 months and no more than 18 months after an early autologous stem cell transplantation (SCT =< 12 months of diagnosis).
Patient must not be off lenalidomide maintenance therapy for more than 30 days prior to start of treatment on Step 1 of this protocol.
  • - Patient must be able to undergo a diagnostic bone marrow aspirate following pre-registration to Step 0.
  • - NOTE: A bone marrow aspirate specimen must be submitted to Mayo Clinic Hematology Laboratory for central assessment of minimal residual disease (MRD) status to confirm patient's eligibility for Step 1 randomization.
Mayo Clinic will forward results to the submitting institution within three
  • (3) business days of receipt of the bone marrow specimen.
  • - Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2.
  • - Patient must have been able to maintain at least 5mg daily dose of lenalidomide without growth factor support.
  • - Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial.
  • - STEP 1 RANDOMIZATION.
  • - Patient must meet Step 0 eligibility criteria at the time of Step 1 randomization.
  • - Patients must have evidence of residual disease by central MRD testing or by presence of monoclonal protein in serum or urine.
  • - Patient must have serum protein electrophoresis (SPEP), urine protein electrophoresis (UPEP), and serum free light chain (FLC) performed =< 28 days prior to randomization.
  • - NOTE: UPEP (on a 24-hour collection) is required, no substitute method is acceptable.
Urine must be followed monthly if the baseline urine M-spike is >= 200 mg/24 hour (hr). Please note that if both serum and urine M-components are present, both must be followed in order to evaluate response.
  • - Hemoglobin >= 8 g/dL (obtained =< 14 days prior to randomization) - Untransfused platelet count >= 75,000 cells/mm^3 (obtained =< 14 days prior to randomization) - Absolute neutrophil count (ANC) >= 1000 cells/mm^3 (obtained =< 14 days prior to randomization) - Calculated creatinine clearance >= 30 mL/min (obtained =< 14 days prior to randomization) - Total bilirubin =< 1.5 times the upper limit of normal (ULN) (obtained =< 14 days prior to randomization) - Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) and serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< 3 times the upper limit of normal (ULN) (obtained =< 14 days prior to randomization) - Patient must agree to register into the mandatory Revlimid Risk Evaluation and Mitigation Strategies (REMS) registered trademark program and be willing and able to comply with the requirements of Revlimid REMS registered trademark.
  • - Patients of childbearing potential must either abstain from sexual intercourse for the duration of their participation in the study or agree to use TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME for 1) at least 28 days before starting study treatment; 2) while participating in the study; 3) during dose interruptions; and 4) for at least 90 days after the last dose of protocol treatment.
Patients must also agree to not breastfeed during this same time period. Men must agree to either abstain from sexual intercourse for the duration of their participation in the study or use a latex condom during sexual contact with a partner of childbearing potential while participating in the study and for 90 days after the last dose of protocol treatment even if they have had a successful vasectomy. Patients must also agree to abstain from donating sperm while on study treatment and for 28 days after the last dose of protocol treatment even if they have had a successful vasectomy. All patients must agree to abstain from donating blood during study participation and for at least 28 days after the last dose of protocol treatment.

Exclusion Criteria:

  • - Patient must not have primary refractory or progressive disease on a proteasome inhibitor-based regimen during induction therapy prior to stem cell transplant.
  • - Patient must not be on other concurrent chemotherapy, or any ancillary therapy considered investigational.
  • - NOTE: Bisphosphonates are considered to be supportive care rather than therapy and are allowed while on protocol treatment.
  • - Patient must not have uncontrolled psychiatric illness or social situations that would limit compliance with study requirements.
  • - Patient must not have another malignancy requiring treatment or have received treatment within two years before pre-registration or previously diagnosed with another malignancy and have any evidence of residual disease.
Patients with non-melanoma skin cancer or carcinoma in situ of any type are not excluded if they have undergone complete resection.
  • - Patients must not have known gastrointestinal (GI) disease or GI procedure that could interfere with the oral absorption or tolerance of ixazomib or lenalidomide including difficulty swallowing.
  • - Patient must not have known hepatitis B surface antigen-positive status or known or suspected active hepatitis C infection, but testing specifically for the trial is not required.
  • - Patient must not be off lenalidomide maintenance therapy for more than 30 days prior to start of treatment on Step 1 of this protocol.
  • - Patients must not have grade 2 or higher peripheral neuropathy or grade 1 peripheral neuropathy with pain per Common Terminology Criteria for Adverse Events (CTCAE) - Patients must not have uncontrolled intercurrent illness.
  • - Patients must not have grade 2 or higher diarrhea per CTCAE in the absence of antidiarrheals.
  • - Patients must not have been on systemic treatment, within 14 days before the first dose of ixazomib, with strong CYP3A inducers (such as rifampin, rifapentine, rifabutin, carbamazepine, phenytoin, phenobarbital), or use of St. John's wort.
  • - Patient must not be pregnant due to potential harm to the fetus from ixazomib and lenalidomide.
All patients of childbearing potential must have a blood test or urine study with a sensitivity of at least 25 mIU/mL within 10-14 days prior to the first dose of lenalidomide and again within 24 hours prior to the first dose of lenalidomide. Patients of childbearing potential must also agree to ongoing pregnancy testing while on treatment. A patient of childbearing potential is defined as anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy, or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT03941860
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Phase 3
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

National Cancer Institute (NCI)
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Shaji K Kumar
Principal Investigator Affiliation ECOG-ACRIN Cancer Research Group
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

NIH
Overall Status Recruiting
Countries Puerto Rico, United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Plasma Cell Myeloma
Additional Details

PRIMARY OBJECTIVE:

  • I. To evaluate whether escalating maintenance therapy with the addition of ixazomib citrate (ixazomib) to lenalidomide improves overall survival (OS) among patients who are minimal residual disease (MRD) positive after approximately 1 year of lenalidomide maintenance following an early stem cell transplant (=< 12 months from diagnosis).
SECONDARY OBJECTIVES:
  • I. To establish whether progression-free survival (PFS) is superior with the addition of ixazomib to lenalidomide maintenance.
  • II. To evaluate best response on treatment and compare response rates between arms.
  • III. To evaluate the safety profile of ixazomib added to lenalidomide and compare toxicity rates between arms.
EXPLORATORY OBJECTIVES:
  • I. To measure treatment exposure and adherence.
  • II. To estimate treatment duration, duration of response and time to progression.
PATIENT-REPORTED OUTCOMES (PRO) OBJECTIVES:
  • I. To quantify the extent to which the addition of ixazomib to lenalidomide maintenance contributes to neuropathy and associated physical and functional impairments.
(Primary)
  • II. To assess the impact of the addition of ixazomib to lenalidomide maintenance on disease control and associated physical and functional well-being.
(Primary)
  • III. To evaluate time to worsening and recovery rate related to neuropathy.
(Secondary)
  • IV. To evaluate time to improvement and response rate related to disease control.
(Secondary)
  • V. To evaluate attributes of select patient reported treatment-emergent symptomatic adverse events (Patient-Reported Outcomes - Common Terminology Criteria for Adverse Events [PRO-CTCAE]) longitudinally and compare responses with provider-reported adverse events.
(Exploratory)
  • VI. To measure the likelihood of medication adherence and examine the relationship with treatment exposure.
(Exploratory)
  • VII. To assess correlation among patient reported outcome measures and association with clinical outcomes.
(Exploratory)
  • VIII. To tabulate PRO compliance and completion rates.
(Exploratory) IMAGING OBJECTIVES:
  • I. To evaluate the association between baseline fludeoxyglucose F-18 (18F-FDG)-positron emission tomography (PET)/computed tomography (CT) and patient outcomes.
  • II. To compare overall survival (OS) with the addition of ixazomib to lenalidomide among baseline 18F-FDG PET/CT-positive and 18F-FDG PET/CT -negative subgroups.
  • III. To compare the change in quantitative 18F-FDG PET/CT parameters over time with the addition of ixazomib to lenalidomide.
OUTLINE: Patients are randomized to 1 of 2 arms. ARM A: Patients receive lenalidomide orally (PO) once daily (QD) on days 1-28 and ixazomib citrate PO on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo bone marrow aspirate and/or biopsy and positron emission tomography (PET) and computed tomography (CT) scan at screening and on study as well as undergo collection of blood samples throughout the trial. ARM B: Patients receive lenalidomide PO QD on days 1-28 and a placebo PO on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo bone marrow aspirate and/or biopsy and PET and CT scan at screening and on study as well as undergo collection of blood samples throughout the trial. After completion of study treatment, patients are followed up every 3 months if < 2 years from study entry, every 6 months if 2-5 years from study entry, then every 12 months for up to 10 years from study entry.

Arms & Interventions

Arms

Experimental: Arm A (lenalidomide, ixazomib citrate)

Patients receive lenalidomide PO QD on days 1-28 and ixazomib citrate PO on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo bone marrow aspirate and/or biopsy and PET and CT scan at screening and on study as well as undergo collection of blood samples throughout the trial.

Placebo Comparator: Arm B (lenalidomide, placebo)

Patients receive lenalidomide PO QD on days 1-28 and a placebo PO on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo bone marrow aspirate and/or biopsy and PET and CT scan at screening and on study as well as undergo collection of blood samples throughout the trial.

Interventions

Procedure: - Biospecimen Collection

Undergo collection of blood samples

Procedure: - Bone Marrow Aspirate

Undergo bone marrow aspirate

Procedure: - Bone Marrow Biopsy

Undergo bone marrow biopsy

Procedure: - Computed Tomography

Undergo CT scan

Drug: - Ixazomib Citrate

Given PO

Drug: - Lenalidomide

Given PO

Other: - Placebo Administration

Given PO

Procedure: - Positron Emission Tomography

Undergo PET scan

Other: - Quality-of-Life Assessment

Ancillary studies

Other: - Questionnaire Administration

Ancillary studies

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Cancer Center at Saint Joseph's, Phoenix, Arizona

Status

Suspended

Address

Cancer Center at Saint Joseph's

Phoenix, Arizona, 85004

Hot Springs, Arkansas

Status

Suspended

Address

CHI Saint Vincent Cancer Center Hot Springs

Hot Springs, Arkansas, 71913

Arroyo Grande, California

Status

Suspended

Address

Mission Hope Medical Oncology - Arroyo Grande

Arroyo Grande, California, 93420

San Luis Obispo, California

Status

Suspended

Address

Pacific Central Coast Health Center-San Luis Obispo

San Luis Obispo, California, 93401

Santa Maria, California

Status

Suspended

Address

Mission Hope Medical Oncology - Santa Maria

Santa Maria, California, 93444

Penrose-Saint Francis Healthcare, Colorado Springs, Colorado

Status

Suspended

Address

Penrose-Saint Francis Healthcare

Colorado Springs, Colorado, 80907

Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado

Status

Suspended

Address

Rocky Mountain Cancer Centers-Penrose

Colorado Springs, Colorado, 80907

Porter Adventist Hospital, Denver, Colorado

Status

Suspended

Address

Porter Adventist Hospital

Denver, Colorado, 80210

Mercy Medical Center, Durango, Colorado

Status

Suspended

Address

Mercy Medical Center

Durango, Colorado, 81301

Southwest Oncology PC, Durango, Colorado

Status

Suspended

Address

Southwest Oncology PC

Durango, Colorado, 81301

Saint Anthony Hospital, Lakewood, Colorado

Status

Suspended

Address

Saint Anthony Hospital

Lakewood, Colorado, 80228

Littleton Adventist Hospital, Littleton, Colorado

Status

Suspended

Address

Littleton Adventist Hospital

Littleton, Colorado, 80122

Longmont United Hospital, Longmont, Colorado

Status

Suspended

Address

Longmont United Hospital

Longmont, Colorado, 80501

Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado

Status

Suspended

Address

Rocky Mountain Cancer Centers-Longmont

Longmont, Colorado, 80501

Parker Adventist Hospital, Parker, Colorado

Status

Suspended

Address

Parker Adventist Hospital

Parker, Colorado, 80138

Saint Mary Corwin Medical Center, Pueblo, Colorado

Status

Suspended

Address

Saint Mary Corwin Medical Center

Pueblo, Colorado, 81004

Rush - Copley Medical Center, Aurora, Illinois

Status

Suspended

Address

Rush - Copley Medical Center

Aurora, Illinois, 60504

Illinois CancerCare-Bloomington, Bloomington, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Bloomington

Bloomington, Illinois, 61704

Illinois CancerCare-Canton, Canton, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Canton

Canton, Illinois, 61520

Memorial Hospital of Carbondale, Carbondale, Illinois

Status

Suspended

Address

Memorial Hospital of Carbondale

Carbondale, Illinois, 62902

SIH Cancer Institute, Carterville, Illinois

Status

Suspended

Address

SIH Cancer Institute

Carterville, Illinois, 62918

Illinois CancerCare-Carthage, Carthage, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Carthage

Carthage, Illinois, 62321

Centralia Oncology Clinic, Centralia, Illinois

Status

Recruiting

Address

Centralia Oncology Clinic

Centralia, Illinois, 62801

Site Contact

Site Public Contact

morganthaler.jodi@mhsil.com

217-876-4762

Carle on Vermilion, Danville, Illinois

Status

Recruiting

Address

Carle on Vermilion

Danville, Illinois, 61832

Site Contact

Site Public Contact

Research@carle.com

800-446-5532

Decatur, Illinois

Status

Recruiting

Address

Cancer Care Specialists of Illinois - Decatur

Decatur, Illinois, 62526

Site Contact

Site Public Contact

morganthaler.jodi@mhsil.com

217-876-4762

Decatur Memorial Hospital, Decatur, Illinois

Status

Suspended

Address

Decatur Memorial Hospital

Decatur, Illinois, 62526

Illinois CancerCare-Dixon, Dixon, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Dixon

Dixon, Illinois, 61021

Carle Physician Group-Effingham, Effingham, Illinois

Status

Recruiting

Address

Carle Physician Group-Effingham

Effingham, Illinois, 62401

Site Contact

Site Public Contact

Research@carle.com

800-446-5532

Crossroads Cancer Center, Effingham, Illinois

Status

Recruiting

Address

Crossroads Cancer Center

Effingham, Illinois, 62401

Site Contact

Site Public Contact

morganthaler.jodi@mhsil.com

217-876-4762

Illinois CancerCare-Eureka, Eureka, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Eureka

Eureka, Illinois, 61530

Illinois CancerCare-Galesburg, Galesburg, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Galesburg

Galesburg, Illinois, 61401

Western Illinois Cancer Treatment Center, Galesburg, Illinois

Status

Suspended

Address

Western Illinois Cancer Treatment Center

Galesburg, Illinois, 61401

Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Kewanee Clinic

Kewanee, Illinois, 61443

Illinois CancerCare-Macomb, Macomb, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Macomb

Macomb, Illinois, 61455

Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois

Status

Recruiting

Address

Carle Physician Group-Mattoon/Charleston

Mattoon, Illinois, 61938

Site Contact

Site Public Contact

Research@carle.com

800-446-5532

Cancer Care Center of O'Fallon, O'Fallon, Illinois

Status

Recruiting

Address

Cancer Care Center of O'Fallon

O'Fallon, Illinois, 62269

Site Contact

Site Public Contact

morganthaler.jodi@mhsil.com

217-876-4762

Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Ottawa Clinic

Ottawa, Illinois, 61350

Illinois CancerCare-Pekin, Pekin, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Pekin

Pekin, Illinois, 61554

Illinois CancerCare-Peoria, Peoria, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Peoria

Peoria, Illinois, 61615

Methodist Medical Center of Illinois, Peoria, Illinois

Status

Suspended

Address

Methodist Medical Center of Illinois

Peoria, Illinois, 61636

Illinois CancerCare-Peru, Peru, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Peru

Peru, Illinois, 61354

Valley Radiation Oncology, Peru, Illinois

Status

Suspended

Address

Valley Radiation Oncology

Peru, Illinois, 61354

Illinois CancerCare-Princeton, Princeton, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare-Princeton

Princeton, Illinois, 61356

Springfield, Illinois

Status

Recruiting

Address

Southern Illinois University School of Medicine

Springfield, Illinois, 62702

Site Contact

Site Public Contact

217-545-7929

Springfield Clinic, Springfield, Illinois

Status

Recruiting

Address

Springfield Clinic

Springfield, Illinois, 62702

Site Contact

Site Public Contact

800-444-7541

Memorial Medical Center, Springfield, Illinois

Status

Suspended

Address

Memorial Medical Center

Springfield, Illinois, 62781

Carle Cancer Center, Urbana, Illinois

Status

Recruiting

Address

Carle Cancer Center

Urbana, Illinois, 61801

Site Contact

Site Public Contact

Research@carle.com

800-446-5532

The Carle Foundation Hospital, Urbana, Illinois

Status

Suspended

Address

The Carle Foundation Hospital

Urbana, Illinois, 61801

Illinois CancerCare - Washington, Washington, Illinois

Status

Active, not recruiting

Address

Illinois CancerCare - Washington

Washington, Illinois, 61571

Rush-Copley Healthcare Center, Yorkville, Illinois

Status

Suspended

Address

Rush-Copley Healthcare Center

Yorkville, Illinois, 60560

Mary Greeley Medical Center, Ames, Iowa

Status

Recruiting

Address

Mary Greeley Medical Center

Ames, Iowa, 50010

Site Contact

Site Public Contact

515-956-4132

McFarland Clinic PC - Ames, Ames, Iowa

Status

Recruiting

Address

McFarland Clinic PC - Ames

Ames, Iowa, 50010

Site Contact

Site Public Contact

ksoder@mcfarlandclinic.com

515-239-4734

McFarland Clinic PC-Boone, Boone, Iowa

Status

Recruiting

Address

McFarland Clinic PC-Boone

Boone, Iowa, 50036

Site Contact

Site Public Contact

515-956-4132

Saint Anthony Regional Hospital, Carroll, Iowa

Status

Suspended

Address

Saint Anthony Regional Hospital

Carroll, Iowa, 51401

Clive, Iowa

Status

Suspended

Address

Medical Oncology and Hematology Associates-West Des Moines

Clive, Iowa, 50325

Mercy Cancer Center-West Lakes, Clive, Iowa

Status

Suspended

Address

Mercy Cancer Center-West Lakes

Clive, Iowa, 50325

Alegent Health Mercy Hospital, Council Bluffs, Iowa

Status

Suspended

Address

Alegent Health Mercy Hospital

Council Bluffs, Iowa, 51503

Greater Regional Medical Center, Creston, Iowa

Status

Suspended

Address

Greater Regional Medical Center

Creston, Iowa, 50801

Iowa Methodist Medical Center, Des Moines, Iowa

Status

Recruiting

Address

Iowa Methodist Medical Center

Des Moines, Iowa, 50309

Site Contact

Site Public Contact

515-241-6727

Des Moines, Iowa

Status

Suspended

Address

Medical Oncology and Hematology Associates-Des Moines

Des Moines, Iowa, 50309

Broadlawns Medical Center, Des Moines, Iowa

Status

Suspended

Address

Broadlawns Medical Center

Des Moines, Iowa, 50314

Mercy Medical Center - Des Moines, Des Moines, Iowa

Status

Suspended

Address

Mercy Medical Center - Des Moines

Des Moines, Iowa, 50314

Mission Cancer and Blood - Laurel, Des Moines, Iowa

Status

Suspended

Address

Mission Cancer and Blood - Laurel

Des Moines, Iowa, 50314

Iowa Lutheran Hospital, Des Moines, Iowa

Status

Suspended

Address

Iowa Lutheran Hospital

Des Moines, Iowa, 50316

Fort Dodge, Iowa

Status

Recruiting

Address

McFarland Clinic PC-Trinity Cancer Center

Fort Dodge, Iowa, 50501

Site Contact

Site Public Contact

515-956-4132

Trinity Regional Medical Center, Fort Dodge, Iowa

Status

Suspended

Address

Trinity Regional Medical Center

Fort Dodge, Iowa, 50501

McFarland Clinic PC-Jefferson, Jefferson, Iowa

Status

Recruiting

Address

McFarland Clinic PC-Jefferson

Jefferson, Iowa, 50129

Site Contact

Site Public Contact

515-956-4132

McFarland Clinic PC-Marshalltown, Marshalltown, Iowa

Status

Recruiting

Address

McFarland Clinic PC-Marshalltown

Marshalltown, Iowa, 50158

Site Contact

Site Public Contact

515-956-4132

Methodist West Hospital, West Des Moines, Iowa

Status

Suspended

Address

Methodist West Hospital

West Des Moines, Iowa, 50266-7700

Mercy Medical Center-West Lakes, West Des Moines, Iowa

Status

Suspended

Address

Mercy Medical Center-West Lakes

West Des Moines, Iowa, 50266

Wichita, Kansas

Status

Recruiting

Address

Cancer Center of Kansas-Wichita Medical Arts Tower

Wichita, Kansas, 67208

Site Contact

Site Public Contact

Keisha.humphries@ascension.org

316-268-5374

Ascension Via Christi Hospitals Wichita, Wichita, Kansas

Status

Recruiting

Address

Ascension Via Christi Hospitals Wichita

Wichita, Kansas, 67214

Site Contact

Site Public Contact

Keisha.humphries@ascension.org

800-362-0070

Cancer Center of Kansas - Wichita, Wichita, Kansas

Status

Recruiting

Address

Cancer Center of Kansas - Wichita

Wichita, Kansas, 67214

Site Contact

Site Public Contact

Keisha.humphries@ascension.org

316-268-5374

Flaget Memorial Hospital, Bardstown, Kentucky

Status

Suspended

Address

Flaget Memorial Hospital

Bardstown, Kentucky, 40004

Commonwealth Cancer Center-Corbin, Corbin, Kentucky

Status

Suspended

Address

Commonwealth Cancer Center-Corbin

Corbin, Kentucky, 40701

Lexington, Kentucky

Status

Suspended

Address

Saint Joseph Radiation Oncology Resource Center

Lexington, Kentucky, 40504

Saint Joseph Hospital East, Lexington, Kentucky

Status

Suspended

Address

Saint Joseph Hospital East

Lexington, Kentucky, 40509

Saint Joseph London, London, Kentucky

Status

Suspended

Address

Saint Joseph London

London, Kentucky, 40741

Jewish Hospital, Louisville, Kentucky

Status

Suspended

Address

Jewish Hospital

Louisville, Kentucky, 40202

Saints Mary and Elizabeth Hospital, Louisville, Kentucky

Status

Suspended

Address

Saints Mary and Elizabeth Hospital

Louisville, Kentucky, 40215

UofL Health Medical Center Northeast, Louisville, Kentucky

Status

Suspended

Address

UofL Health Medical Center Northeast

Louisville, Kentucky, 40245

Jewish Hospital Medical Center South, Shepherdsville, Kentucky

Status

Suspended

Address

Jewish Hospital Medical Center South

Shepherdsville, Kentucky, 40165

Tufts Medical Center, Boston, Massachusetts

Status

Recruiting

Address

Tufts Medical Center

Boston, Massachusetts, 02111

Saint Joseph Mercy Hospital, Ann Arbor, Michigan

Status

Recruiting

Address

Saint Joseph Mercy Hospital

Ann Arbor, Michigan, 48106

Site Contact

Site Public Contact

MCRCwebsitecontactform@stjoeshealth.org

734-712-7251

Ann Arbor, Michigan

Status

Recruiting

Address

University of Michigan Comprehensive Cancer Center

Ann Arbor, Michigan, 48109

Site Contact

Site Public Contact

800-865-1125

Bronson Battle Creek, Battle Creek, Michigan

Status

Recruiting

Address

Bronson Battle Creek

Battle Creek, Michigan, 49017

Site Contact

Site Public Contact

crcwm-regulatory@crcwm.org

616-391-1230

Saint Joseph Mercy Brighton, Brighton, Michigan

Status

Recruiting

Address

Saint Joseph Mercy Brighton

Brighton, Michigan, 48114

Site Contact

Site Public Contact

MCRCwebsitecontactform@stjoeshealth.org

734-712-7251

Brighton, Michigan

Status

Recruiting

Address

Trinity Health IHA Medical Group Hematology Oncology - Brighton

Brighton, Michigan, 48114

Site Contact

Site Public Contact

MCRCwebsitecontactform@stjoeshealth.org

734-712-7251

Saint Joseph Mercy Canton, Canton, Michigan

Status

Recruiting

Address

Saint Joseph Mercy Canton

Canton, Michigan, 48188

Site Contact

Site Public Contact

MCRCwebsitecontactform@stjoeshealth.org

734-712-7251

Canton, Michigan

Status

Recruiting

Address

Trinity Health IHA Medical Group Hematology Oncology - Canton

Canton, Michigan, 48188

Site Contact

Site Public Contact

MCRCwebsitecontactform@stjoeshealth.org

734-712-7251

Saint Joseph Mercy Chelsea, Chelsea, Michigan

Status

Recruiting

Address

Saint Joseph Mercy Chelsea

Chelsea, Michigan, 48118

Site Contact

Site Public Contact

MCRCwebsitecontactform@stjoeshealth.org

734-712-7251

Chelsea, Michigan

Status

Recruiting

Address

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

Chelsea, Michigan, 48118

Site Contact

Site Public Contact

MCRCwebsitecontactform@stjoeshealth.org

734-712-7251

Ascension Saint John Hospital, Detroit, Michigan

Status

Recruiting

Address

Ascension Saint John Hospital

Detroit, Michigan, 48236

Site Contact

Site Public Contact

karen.forman@ascension.org

313-343-3166

East China Township, Michigan

Status

Recruiting

Address

Great Lakes Cancer Management Specialists-Doctors Park

East China Township, Michigan, 48054

Site Contact

Site Public Contact

karen.forman@ascension.org

313-343-3166

Flint, Michigan

Status

Recruiting

Address

Genesee Cancer and Blood Disease Treatment Center

Flint, Michigan, 48503

Site Contact

Site Public Contact

wstrong@ghci.org

810-762-8038

Genesee Hematology Oncology PC, Flint, Michigan

Status

Recruiting

Address

Genesee Hematology Oncology PC

Flint, Michigan, 48503

Site Contact

Site Public Contact

wstrong@ghci.org

810-762-8038

Genesys Hurley Cancer Institute, Flint, Michigan

Status

Recruiting

Address

Genesys Hurley Cancer Institute

Flint, Michigan, 48503

Site Contact

Site Public Contact

wstrong@ghci.org

810-762-8038

Spectrum Health at Butterworth Campus, Grand Rapids, Michigan

Status

Recruiting

Address

Spectrum Health at Butterworth Campus

Grand Rapids, Michigan, 49503

Site Contact

Site Public Contact

crcwm-regulatory@crcwm.org

616-391-1230

Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan

Status

Recruiting

Address

Trinity Health Grand Rapids Hospital

Grand Rapids, Michigan, 49503

Site Contact

Site Public Contact

crcwm-regulatory@crcwm.org

616-391-1230

Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan

Status

Recruiting

Address

Academic Hematology Oncology Specialists

Grosse Pointe Woods, Michigan, 48236

Site Contact

Site Public Contact

karen.forman@ascension.org

313-343-3166

Grosse Pointe Woods, Michigan

Status

Recruiting

Address

Great Lakes Cancer Management Specialists-Van Elslander Cancer Center

Grosse Pointe Woods, Michigan, 48236

Site Contact

Site Public Contact

karen.forman@ascension.org

313-343-3166

Bronson Methodist Hospital, Kalamazoo, Michigan

Status

Recruiting

Address

Bronson Methodist Hospital

Kalamazoo, Michigan, 49007

Site Contact

Site Public Contact

crcwm-regulatory@crcwm.org

616-391-1230

West Michigan Cancer Center, Kalamazoo, Michigan

Status

Recruiting

Address

West Michigan Cancer Center

Kalamazoo, Michigan, 49007

Site Contact

Site Public Contact

crcwm-regulatory@crcwm.org

616-391-1230

Ascension Borgess Cancer Center, Kalamazoo, Michigan

Status

Recruiting

Address

Ascension Borgess Cancer Center

Kalamazoo, Michigan, 49009

Site Contact

Site Public Contact

crcwm-regulatory@crcwm.org

616-391-1230

Livonia, Michigan

Status

Recruiting

Address

Trinity Health Saint Mary Mercy Livonia Hospital

Livonia, Michigan, 48154

Site Contact

Site Public Contact

MCRCwebsitecontactform@stjoeshealth.org

734-712-7251

Macomb, Michigan

Status

Recruiting

Address

Great Lakes Cancer Management Specialists-Macomb Medical Campus

Macomb, Michigan, 48044

Site Contact

Site Public Contact

karen.forman@ascension.org

313-343-3166

Trinity Health Muskegon Hospital, Muskegon, Michigan

Status

Recruiting

Address

Trinity Health Muskegon Hospital

Muskegon, Michigan, 49444

Site Contact

Site Public Contact

crcwm-regulatory@crcwm.org

616-391-1230

Norton Shores, Michigan

Status

Recruiting

Address

Cancer and Hematology Centers of Western Michigan - Norton Shores

Norton Shores, Michigan, 49444

Site Contact

Site Public Contact

connie.szczepanek@crcwm.org

616-391-1230

Spectrum Health Reed City Hospital, Reed City, Michigan

Status

Recruiting

Address

Spectrum Health Reed City Hospital

Reed City, Michigan, 49677

Site Contact

Site Public Contact

crcwm-regulatory@crcwm.org

616-391-1230

Marie Yeager Cancer Center, Saint Joseph, Michigan

Status

Recruiting

Address

Marie Yeager Cancer Center

Saint Joseph, Michigan, 49085

Site Contact

Site Public Contact

crcwm-regulatory@crcwm.org

616-391-1230

Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan

Status

Recruiting

Address

Bhadresh Nayak MD PC-Sterling Heights

Sterling Heights, Michigan, 48312

Site Contact

Site Public Contact

karen.forman@ascension.org

313-343-3166

Munson Medical Center, Traverse City, Michigan

Status

Recruiting

Address

Munson Medical Center

Traverse City, Michigan, 49684

Site Contact

Site Public Contact

crcwm-regulatory@crcwm.org

616-391-1230

Warren, Michigan

Status

Recruiting

Address

Great Lakes Cancer Management Specialists-Macomb Professional Building

Warren, Michigan, 48093

Site Contact

Site Public Contact

karen.forman@ascension.org

313-343-3166

Macomb Hematology Oncology PC, Warren, Michigan

Status

Recruiting

Address

Macomb Hematology Oncology PC

Warren, Michigan, 48093

Site Contact

Site Public Contact

karen.forman@ascension.org

313-343-3166

Saint John Macomb-Oakland Hospital, Warren, Michigan

Status

Recruiting

Address

Saint John Macomb-Oakland Hospital

Warren, Michigan, 48093

Site Contact

Site Public Contact

karen.forman@ascension.org

313-343-3166

Metro Health Hospital, Wyoming, Michigan

Status

Recruiting

Address

Metro Health Hospital

Wyoming, Michigan, 49519

Site Contact

Site Public Contact

crcwm-regulatory@crcwm.org

616-391-1230

Huron Gastroenterology PC, Ypsilanti, Michigan

Status

Recruiting

Address

Huron Gastroenterology PC

Ypsilanti, Michigan, 48106

Site Contact

Site Public Contact

MCRCwebsitecontactform@stjoeshealth.org

734-712-7251

Ypsilanti, Michigan

Status

Recruiting

Address

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

Ypsilanti, Michigan, 48197

Site Contact

Site Public Contact

MCRCwebsitecontactform@stjoeshealth.org

734-712-7251

Sanford Joe Lueken Cancer Center, Bemidji, Minnesota

Status

Recruiting

Address

Sanford Joe Lueken Cancer Center

Bemidji, Minnesota, 56601

Fairview Ridges Hospital, Burnsville, Minnesota

Status

Suspended

Address

Fairview Ridges Hospital

Burnsville, Minnesota, 55337

Minnesota Oncology - Burnsville, Burnsville, Minnesota

Status

Suspended

Address

Minnesota Oncology - Burnsville

Burnsville, Minnesota, 55337

Cambridge Medical Center, Cambridge, Minnesota

Status

Suspended

Address

Cambridge Medical Center

Cambridge, Minnesota, 55008

Mercy Hospital, Coon Rapids, Minnesota

Status

Suspended

Address

Mercy Hospital

Coon Rapids, Minnesota, 55433

Fairview Southdale Hospital, Edina, Minnesota

Status

Suspended

Address

Fairview Southdale Hospital

Edina, Minnesota, 55435

Unity Hospital, Fridley, Minnesota

Status

Suspended

Address

Unity Hospital

Fridley, Minnesota, 55432

Maple Grove, Minnesota

Status

Suspended

Address

Fairview Clinics and Surgery Center Maple Grove

Maple Grove, Minnesota, 55369

Maplewood, Minnesota

Status

Suspended

Address

Minnesota Oncology Hematology PA-Maplewood

Maplewood, Minnesota, 55109

Saint John's Hospital - Healtheast, Maplewood, Minnesota

Status

Suspended

Address

Saint John's Hospital - Healtheast

Maplewood, Minnesota, 55109

Abbott-Northwestern Hospital, Minneapolis, Minnesota

Status

Suspended

Address

Abbott-Northwestern Hospital

Minneapolis, Minnesota, 55407

Hennepin County Medical Center, Minneapolis, Minnesota

Status

Recruiting

Address

Hennepin County Medical Center

Minneapolis, Minnesota, 55415

Site Contact

Site Public Contact

mmcorc@healthpartners.com

952-993-1517

Health Partners Inc, Minneapolis, Minnesota

Status

Suspended

Address

Health Partners Inc

Minneapolis, Minnesota, 55454

Monticello Cancer Center, Monticello, Minnesota

Status

Suspended

Address

Monticello Cancer Center

Monticello, Minnesota, 55362

New Ulm Medical Center, New Ulm, Minnesota

Status

Suspended

Address

New Ulm Medical Center

New Ulm, Minnesota, 56073

Fairview Northland Medical Center, Princeton, Minnesota

Status

Suspended

Address

Fairview Northland Medical Center

Princeton, Minnesota, 55371

North Memorial Medical Health Center, Robbinsdale, Minnesota

Status

Suspended

Address

North Memorial Medical Health Center

Robbinsdale, Minnesota, 55422

Mayo Clinic in Rochester, Rochester, Minnesota

Status

Recruiting

Address

Mayo Clinic in Rochester

Rochester, Minnesota, 55905

Site Contact

Site Public Contact

855-776-0015

Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota

Status

Suspended

Address

Park Nicollet Clinic - Saint Louis Park

Saint Louis Park, Minnesota, 55416

Regions Hospital, Saint Paul, Minnesota

Status

Suspended

Address

Regions Hospital

Saint Paul, Minnesota, 55101

United Hospital, Saint Paul, Minnesota

Status

Suspended

Address

United Hospital

Saint Paul, Minnesota, 55102

Saint Francis Regional Medical Center, Shakopee, Minnesota

Status

Suspended

Address

Saint Francis Regional Medical Center

Shakopee, Minnesota, 55379

Lakeview Hospital, Stillwater, Minnesota

Status

Suspended

Address

Lakeview Hospital

Stillwater, Minnesota, 55082

Ridgeview Medical Center, Waconia, Minnesota

Status

Suspended

Address

Ridgeview Medical Center

Waconia, Minnesota, 55387

Rice Memorial Hospital, Willmar, Minnesota

Status

Suspended

Address

Rice Memorial Hospital

Willmar, Minnesota, 56201

Woodbury, Minnesota

Status

Suspended

Address

Minnesota Oncology Hematology PA-Woodbury

Woodbury, Minnesota, 55125

Fairview Lakes Medical Center, Wyoming, Minnesota

Status

Suspended

Address

Fairview Lakes Medical Center

Wyoming, Minnesota, 55092

Saint Francis Medical Center, Cape Girardeau, Missouri

Status

Recruiting

Address

Saint Francis Medical Center

Cape Girardeau, Missouri, 63703

Site Contact

Site Public Contact

sfmc@sfmc.net

573-334-2230

Southeast Cancer Center, Cape Girardeau, Missouri

Status

Suspended

Address

Southeast Cancer Center

Cape Girardeau, Missouri, 63703

Parkland Health Center - Farmington, Farmington, Missouri

Status

Recruiting

Address

Parkland Health Center - Farmington

Farmington, Missouri, 63640

Site Contact

Site Public Contact

314-996-5569

Capital Region Southwest Campus, Jefferson City, Missouri

Status

Suspended

Address

Capital Region Southwest Campus

Jefferson City, Missouri, 65109

Missouri Baptist Medical Center, Saint Louis, Missouri

Status

Recruiting

Address

Missouri Baptist Medical Center

Saint Louis, Missouri, 63131

Site Contact

Site Public Contact

314-996-5569

Mercy Hospital Saint Louis, Saint Louis, Missouri

Status

Recruiting

Address

Mercy Hospital Saint Louis

Saint Louis, Missouri, 63141

Site Contact

Site Public Contact

314-251-7066

Sainte Genevieve, Missouri

Status

Recruiting

Address

Sainte Genevieve County Memorial Hospital

Sainte Genevieve, Missouri, 63670

Site Contact

Site Public Contact

314-996-5569

Missouri Baptist Sullivan Hospital, Sullivan, Missouri

Status

Recruiting

Address

Missouri Baptist Sullivan Hospital

Sullivan, Missouri, 63080

Site Contact

Site Public Contact

314-996-5569

Sunset Hills, Missouri

Status

Recruiting

Address

Missouri Baptist Outpatient Center-Sunset Hills

Sunset Hills, Missouri, 63127

Site Contact

Site Public Contact

314-996-5569

CHI Health Saint Francis, Grand Island, Nebraska

Status

Suspended

Address

CHI Health Saint Francis

Grand Island, Nebraska, 68803

CHI Health Good Samaritan, Kearney, Nebraska

Status

Suspended

Address

CHI Health Good Samaritan

Kearney, Nebraska, 68847

Saint Elizabeth Regional Medical Center, Lincoln, Nebraska

Status

Suspended

Address

Saint Elizabeth Regional Medical Center

Lincoln, Nebraska, 68510

Alegent Health Immanuel Medical Center, Omaha, Nebraska

Status

Suspended

Address

Alegent Health Immanuel Medical Center

Omaha, Nebraska, 68122

Omaha, Nebraska

Status

Suspended

Address

Alegent Health Bergan Mercy Medical Center

Omaha, Nebraska, 68124

Alegent Health Lakeside Hospital, Omaha, Nebraska

Status

Suspended

Address

Alegent Health Lakeside Hospital

Omaha, Nebraska, 68130

Creighton University Medical Center, Omaha, Nebraska

Status

Suspended

Address

Creighton University Medical Center

Omaha, Nebraska, 68131

Midlands Community Hospital, Papillion, Nebraska

Status

Suspended

Address

Midlands Community Hospital

Papillion, Nebraska, 68046

Sanford Bismarck Medical Center, Bismarck, North Dakota

Status

Recruiting

Address

Sanford Bismarck Medical Center

Bismarck, North Dakota, 58501

Sanford Broadway Medical Center, Fargo, North Dakota

Status

Recruiting

Address

Sanford Broadway Medical Center

Fargo, North Dakota, 58122

Sanford Roger Maris Cancer Center, Fargo, North Dakota

Status

Recruiting

Address

Sanford Roger Maris Cancer Center

Fargo, North Dakota, 58122

Strecker Cancer Center-Belpre, Belpre, Ohio

Status

Recruiting

Address

Strecker Cancer Center-Belpre

Belpre, Ohio, 45714

Site Contact

Site Public Contact

sheree@columbusccop.org

800-523-3977

Miami Valley Hospital South, Centerville, Ohio

Status

Recruiting

Address

Miami Valley Hospital South

Centerville, Ohio, 45459

Site Contact

Site Public Contact

clinical.trials@daytonncorp.org

937-528-2900

Adena Regional Medical Center, Chillicothe, Ohio

Status

Recruiting

Address

Adena Regional Medical Center

Chillicothe, Ohio, 45601

Site Contact

Site Public Contact

sheree@columbusccop.org

877-779-7585

Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio

Status

Suspended

Address

Good Samaritan Hospital - Cincinnati

Cincinnati, Ohio, 45220

Bethesda North Hospital, Cincinnati, Ohio

Status

Suspended

Address

Bethesda North Hospital

Cincinnati, Ohio, 45242

TriHealth Cancer Institute-Westside, Cincinnati, Ohio

Status

Suspended

Address

TriHealth Cancer Institute-Westside

Cincinnati, Ohio, 45247

TriHealth Cancer Institute-Anderson, Cincinnati, Ohio

Status

Suspended

Address

TriHealth Cancer Institute-Anderson

Cincinnati, Ohio, 45255

Mount Carmel East Hospital, Columbus, Ohio

Status

Recruiting

Address

Mount Carmel East Hospital

Columbus, Ohio, 43213

Site Contact

Site Public Contact

sheree@columbusccop.org

614-488-2118

Columbus, Ohio

Status

Recruiting

Address

Columbus Oncology and Hematology Associates Inc

Columbus, Ohio, 43214

Site Contact

Site Public Contact

sheree@columbusccop.org

614-488-2118

Riverside Methodist Hospital, Columbus, Ohio

Status

Recruiting

Address

Riverside Methodist Hospital

Columbus, Ohio, 43214

Site Contact

Site Public Contact

sheree@columbusccop.org

614-566-4475

Grant Medical Center, Columbus, Ohio

Status

Recruiting

Address

Grant Medical Center

Columbus, Ohio, 43215

Site Contact

Site Public Contact

sheree@columbusccop.org

614-566-4475

The Mark H Zangmeister Center, Columbus, Ohio

Status

Recruiting

Address

The Mark H Zangmeister Center

Columbus, Ohio, 43219

Site Contact

Site Public Contact

sheree@columbusccop.org

614-488-2118

Mount Carmel Health Center West, Columbus, Ohio

Status

Recruiting

Address

Mount Carmel Health Center West

Columbus, Ohio, 43222

Site Contact

Site Public Contact

sheree@columbusccop.org

614-234-5433

Doctors Hospital, Columbus, Ohio

Status

Recruiting

Address

Doctors Hospital

Columbus, Ohio, 43228

Site Contact

Site Public Contact

sheree@columbusccop.org

614-566-3275

Miami Valley Hospital, Dayton, Ohio

Status

Recruiting

Address

Miami Valley Hospital

Dayton, Ohio, 45409

Site Contact

Site Public Contact

clinical.trials@daytonncorp.org

937-528-2900

Miami Valley Hospital North, Dayton, Ohio

Status

Recruiting

Address

Miami Valley Hospital North

Dayton, Ohio, 45415

Site Contact

Site Public Contact

clinical.trials@daytonncorp.org

937-528-2900

Delaware, Ohio

Status

Recruiting

Address

Delaware Health Center-Grady Cancer Center

Delaware, Ohio, 43015

Site Contact

Site Public Contact

sheree@columbusccop.org

740-615-0227

Grady Memorial Hospital, Delaware, Ohio

Status

Recruiting

Address

Grady Memorial Hospital

Delaware, Ohio, 43015

Site Contact

Site Public Contact

sheree@columbusccop.org

740-615-2403

Dublin Methodist Hospital, Dublin, Ohio

Status

Suspended

Address

Dublin Methodist Hospital

Dublin, Ohio, 43016

Franklin, Ohio

Status

Recruiting

Address

Atrium Medical Center-Middletown Regional Hospital

Franklin, Ohio, 45005-1066

Site Contact

Site Public Contact

clinical.trials@daytonncorp.org

937-528-2900

Gahanna, Ohio

Status

Suspended

Address

Central Ohio Breast and Endocrine Surgery

Gahanna, Ohio, 43230

Mount Carmel Grove City Hospital, Grove City, Ohio

Status

Suspended

Address

Mount Carmel Grove City Hospital

Grove City, Ohio, 43123

Fairfield Medical Center, Lancaster, Ohio

Status

Recruiting

Address

Fairfield Medical Center

Lancaster, Ohio, 43130

Site Contact

Site Public Contact

sheree@columbusccop.org

740-687-8863

Saint Rita's Medical Center, Lima, Ohio

Status

Suspended

Address

Saint Rita's Medical Center

Lima, Ohio, 45801

OhioHealth Mansfield Hospital, Mansfield, Ohio

Status

Suspended

Address

OhioHealth Mansfield Hospital

Mansfield, Ohio, 44903

Marietta Memorial Hospital, Marietta, Ohio

Status

Recruiting

Address

Marietta Memorial Hospital

Marietta, Ohio, 45750

Site Contact

Site Public Contact

sheree@columbusccop.org

800-523-3977

OhioHealth Marion General Hospital, Marion, Ohio

Status

Recruiting

Address

OhioHealth Marion General Hospital

Marion, Ohio, 43302

Site Contact

Site Public Contact

sheree@columbusccop.org

614-488-2118

Knox Community Hospital, Mount Vernon, Ohio

Status

Recruiting

Address

Knox Community Hospital

Mount Vernon, Ohio, 43050

Site Contact

Site Public Contact

sheree@columbusccop.org

740-393-9000

Licking Memorial Hospital, Newark, Ohio

Status

Recruiting

Address

Licking Memorial Hospital

Newark, Ohio, 43055

Site Contact

Site Public Contact

sheree@columbusccop.org

740-348-4000

Newark Radiation Oncology, Newark, Ohio

Status

Suspended

Address

Newark Radiation Oncology

Newark, Ohio, 43055

Mercy Health Perrysburg Cancer Center, Perrysburg, Ohio

Status

Suspended

Address

Mercy Health Perrysburg Cancer Center

Perrysburg, Ohio, 43551

Southern Ohio Medical Center, Portsmouth, Ohio

Status

Recruiting

Address

Southern Ohio Medical Center

Portsmouth, Ohio, 45662

Site Contact

Site Public Contact

sheree@columbusccop.org

614-488-2118

Saint Vincent Mercy Medical Center, Toledo, Ohio

Status

Suspended

Address

Saint Vincent Mercy Medical Center

Toledo, Ohio, 43608

Mercy Health - Saint Anne Hospital, Toledo, Ohio

Status

Suspended

Address

Mercy Health - Saint Anne Hospital

Toledo, Ohio, 43623

Upper Valley Medical Center, Troy, Ohio

Status

Recruiting

Address

Upper Valley Medical Center

Troy, Ohio, 45373

Site Contact

Site Public Contact

clinical.trials@daytonncorp.org

937-528-2900

Saint Ann's Hospital, Westerville, Ohio

Status

Recruiting

Address

Saint Ann's Hospital

Westerville, Ohio, 43081

Site Contact

Site Public Contact

sheree@columbusccop.org

614-234-5433

Zanesville, Ohio

Status

Recruiting

Address

Genesis Healthcare System Cancer Care Center

Zanesville, Ohio, 43701

Site Contact

Site Public Contact

sheree@columbusccop.org

740-454-5232

Oklahoma City, Oklahoma

Status

Recruiting

Address

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104

Site Contact

Site Public Contact

ou-clinical-trials@ouhsc.edu

405-271-8777

Tulsa, Oklahoma

Status

Recruiting

Address

Oklahoma Cancer Specialists and Research Institute-Tulsa

Tulsa, Oklahoma, 74146

Site Contact

Site Public Contact

918-505-3200

Hershey, Pennsylvania

Status

Recruiting

Address

Penn State Milton S Hershey Medical Center

Hershey, Pennsylvania, 17033-0850

Site Contact

Site Public Contact

CTO@hmc.psu.edu

717-531-3779

Tidelands Georgetown Memorial Hospital, Georgetown, South Carolina

Status

Active, not recruiting

Address

Tidelands Georgetown Memorial Hospital

Georgetown, South Carolina, 29440

Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota

Status

Recruiting

Address

Sanford Cancer Center Oncology Clinic

Sioux Falls, South Dakota, 57104

Site Contact

Site Public Contact

OncologyClinicTrialsSF@sanfordhealth.org

605-312-3320

Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota

Status

Recruiting

Address

Sanford USD Medical Center - Sioux Falls

Sioux Falls, South Dakota, 57117-5134

Site Contact

Site Public Contact

OncologyClinicalTrialsSF@SanfordHealth.org

605-312-3320

Saint Joseph Regional Cancer Center, Bryan, Texas

Status

Suspended

Address

Saint Joseph Regional Cancer Center

Bryan, Texas, 77802

Harrison Medical Center, Bremerton, Washington

Status

Suspended

Address

Harrison Medical Center

Bremerton, Washington, 98310

Highline Medical Center-Main Campus, Burien, Washington

Status

Suspended

Address

Highline Medical Center-Main Campus

Burien, Washington, 98166

Saint Elizabeth Hospital, Enumclaw, Washington

Status

Suspended

Address

Saint Elizabeth Hospital

Enumclaw, Washington, 98022

Saint Francis Hospital, Federal Way, Washington

Status

Suspended

Address

Saint Francis Hospital

Federal Way, Washington, 98003

Saint Clare Hospital, Lakewood, Washington

Status

Suspended

Address

Saint Clare Hospital

Lakewood, Washington, 98499

Tacoma, Washington

Status

Suspended

Address

Franciscan Research Center-Northwest Medical Plaza

Tacoma, Washington, 98405

ThedaCare Regional Cancer Center, Appleton, Wisconsin

Status

Recruiting

Address

ThedaCare Regional Cancer Center

Appleton, Wisconsin, 54911

Site Contact

Site Public Contact

ResearchDept@thedacare.org

920-364-3604

La Crosse, Wisconsin

Status

Recruiting

Address

Mayo Clinic Health System-Franciscan Healthcare

La Crosse, Wisconsin, 54601

Site Contact

Site Public Contact

855-776-0015

ProHealth D N Greenwald Center, Mukwonago, Wisconsin

Status

Recruiting

Address

ProHealth D N Greenwald Center

Mukwonago, Wisconsin, 53149

Site Contact

Site Public Contact

research.institute@phci.org

Cancer Center of Western Wisconsin, New Richmond, Wisconsin

Status

Suspended

Address

Cancer Center of Western Wisconsin

New Richmond, Wisconsin, 54017

ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin

Status

Recruiting

Address

ProHealth Oconomowoc Memorial Hospital

Oconomowoc, Wisconsin, 53066

Site Contact

Site Public Contact

262-928-7878

ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin

Status

Recruiting

Address

ProHealth Waukesha Memorial Hospital

Waukesha, Wisconsin, 53188

Site Contact

Site Public Contact

262-928-7632

UW Cancer Center at ProHealth Care, Waukesha, Wisconsin

Status

Recruiting

Address

UW Cancer Center at ProHealth Care

Waukesha, Wisconsin, 53188

Site Contact

Site Public Contact

Chanda.miller@phci.org

262-928-5539

International Sites

Centro Comprensivo de Cancer de UPR, San Juan, Puerto Rico

Status

Recruiting

Address

Centro Comprensivo de Cancer de UPR

San Juan, , 00927

Site Contact

Site Public Contact

ecog.rss@jimmy.harvard.edu